Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels, and evidence-based approaches assess causes of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinoma. Objective: The aim was to formulate practice guidelines fo...
Gespeichert in:
| Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2011-02, Vol.96 (2), p.273-288 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 288 |
|---|---|
| container_issue | 2 |
| container_start_page | 273 |
| container_title | The journal of clinical endocrinology and metabolism |
| container_volume | 96 |
| creator | Melmed, Shlomo Casanueva, Felipe F Hoffman, Andrew R Kleinberg, David L Montori, Victor M Schlechte, Janet A Wass, John A. H |
| description | Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels, and evidence-based approaches assess causes of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinoma.
Objective:
The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia.
Participants:
The Task Force consisted of Endocrine Society-appointed experts, a methodologist, and a medical writer.
Evidence:
This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence.
Consensus Process:
One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, The European Society of Endocrinology, and The Pituitary Society reviewed and commented on preliminary drafts of these guidelines.
Conclusions:
Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels. These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinomas in nonpregnant and pregnant subjects. Indications and side effects of therapeutic agents for treating prolactinomas are also presented. |
| doi_str_mv | 10.1210/jc.2010-1692 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1017956608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1017956608</sourcerecordid><originalsourceid>FETCH-LOGICAL-c544t-44fcd1ccab46ae6ab86494f0f2ba709378e5cd4446b0014452da3f59ed1afd7e3</originalsourceid><addsrcrecordid>eNpt0EFLHDEUwPEgLbpab55LLgUPjiaZZGbjTVarBaFCLfQW3iQvJctMZk1mDvvtm2XX9tJT4PHjJfkTcsHZNRec3azttWCcVbzR4ogsuJaqarluP5AFY4JXuhW_TshpzmvGuJSqPiYnggvdaM0XxNwH-B3HHDKF6OhrQpgGjBMdPX3abjBt0tiDnULEIcAtvYv0IbrRpjKgP0YbcNrSVR9isNDTl7SjFunjHByWKX4iHz30Gc8P5xn5-fXhdfVUPX9__La6e66sknKqpPTWcWuhkw1gA92ykVp65kUHLdN1u0RlnZSy6fa_EA5qrzQ6Dt61WJ-Ry_3e8t63GfNkhpAt9j1EHOdsOOOtVk3DloVe7alNY84JvdmkMEDaFmR2Sc3aml1Ss0ta-OfD5rkb0P3F7w0L-HIAkEsEnyDakP-5eqkYU6q4eu_wPeAmYc5mPc4pljb_v_4Pj_KQVA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017956608</pqid></control><display><type>article</type><title>Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><source>EZB Electronic Journals Library</source><source>Oxford Journals</source><source>Journals@Ovid Complete</source><creator>Melmed, Shlomo ; Casanueva, Felipe F ; Hoffman, Andrew R ; Kleinberg, David L ; Montori, Victor M ; Schlechte, Janet A ; Wass, John A. H</creator><creatorcontrib>Melmed, Shlomo ; Casanueva, Felipe F ; Hoffman, Andrew R ; Kleinberg, David L ; Montori, Victor M ; Schlechte, Janet A ; Wass, John A. H ; Endocrine Society</creatorcontrib><description>Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels, and evidence-based approaches assess causes of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinoma.
Objective:
The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia.
Participants:
The Task Force consisted of Endocrine Society-appointed experts, a methodologist, and a medical writer.
Evidence:
This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence.
Consensus Process:
One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, The European Society of Endocrinology, and The Pituitary Society reviewed and commented on preliminary drafts of these guidelines.
Conclusions:
Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels. These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinomas in nonpregnant and pregnant subjects. Indications and side effects of therapeutic agents for treating prolactinomas are also presented.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2010-1692</identifier><identifier>PMID: 21296991</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adenoma ; Adult ; Biological and medical sciences ; Communication ; Conferences ; Endocrinology ; Endocrinopathies ; Evidence-Based Medicine ; Feeding. Feeding behavior ; Female ; Fundamental and applied biological sciences. Psychology ; Humans ; Hyperprolactinemia ; Hyperprolactinemia - chemically induced ; Hyperprolactinemia - diagnosis ; Hyperprolactinemia - etiology ; Hyperprolactinemia - pathology ; Hypothalamus. Hypophysis. Epiphysis (diseases) ; Medical sciences ; Non tumoral diseases. Target tissue resistance. Benign neoplasms ; Pituitary ; Pituitary Neoplasms - complications ; Pituitary Neoplasms - drug therapy ; Pregnancy ; Prolactin ; Prolactinoma - complications ; Prolactinoma - drug therapy ; Side effects ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; Vertebrates: endocrinology ; Vocalization behavior</subject><ispartof>The journal of clinical endocrinology and metabolism, 2011-02, Vol.96 (2), p.273-288</ispartof><rights>Copyright © 2011 by The Endocrine Society</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c544t-44fcd1ccab46ae6ab86494f0f2ba709378e5cd4446b0014452da3f59ed1afd7e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23850055$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21296991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Melmed, Shlomo</creatorcontrib><creatorcontrib>Casanueva, Felipe F</creatorcontrib><creatorcontrib>Hoffman, Andrew R</creatorcontrib><creatorcontrib>Kleinberg, David L</creatorcontrib><creatorcontrib>Montori, Victor M</creatorcontrib><creatorcontrib>Schlechte, Janet A</creatorcontrib><creatorcontrib>Wass, John A. H</creatorcontrib><creatorcontrib>Endocrine Society</creatorcontrib><title>Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels, and evidence-based approaches assess causes of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinoma.
Objective:
The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia.
Participants:
The Task Force consisted of Endocrine Society-appointed experts, a methodologist, and a medical writer.
Evidence:
This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence.
Consensus Process:
One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, The European Society of Endocrinology, and The Pituitary Society reviewed and commented on preliminary drafts of these guidelines.
Conclusions:
Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels. These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinomas in nonpregnant and pregnant subjects. Indications and side effects of therapeutic agents for treating prolactinomas are also presented.</description><subject>Adenoma</subject><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Communication</subject><subject>Conferences</subject><subject>Endocrinology</subject><subject>Endocrinopathies</subject><subject>Evidence-Based Medicine</subject><subject>Feeding. Feeding behavior</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>Hyperprolactinemia</subject><subject>Hyperprolactinemia - chemically induced</subject><subject>Hyperprolactinemia - diagnosis</subject><subject>Hyperprolactinemia - etiology</subject><subject>Hyperprolactinemia - pathology</subject><subject>Hypothalamus. Hypophysis. Epiphysis (diseases)</subject><subject>Medical sciences</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><subject>Pituitary</subject><subject>Pituitary Neoplasms - complications</subject><subject>Pituitary Neoplasms - drug therapy</subject><subject>Pregnancy</subject><subject>Prolactin</subject><subject>Prolactinoma - complications</subject><subject>Prolactinoma - drug therapy</subject><subject>Side effects</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>Vertebrates: endocrinology</subject><subject>Vocalization behavior</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0EFLHDEUwPEgLbpab55LLgUPjiaZZGbjTVarBaFCLfQW3iQvJctMZk1mDvvtm2XX9tJT4PHjJfkTcsHZNRec3azttWCcVbzR4ogsuJaqarluP5AFY4JXuhW_TshpzmvGuJSqPiYnggvdaM0XxNwH-B3HHDKF6OhrQpgGjBMdPX3abjBt0tiDnULEIcAtvYv0IbrRpjKgP0YbcNrSVR9isNDTl7SjFunjHByWKX4iHz30Gc8P5xn5-fXhdfVUPX9__La6e66sknKqpPTWcWuhkw1gA92ykVp65kUHLdN1u0RlnZSy6fa_EA5qrzQ6Dt61WJ-Ry_3e8t63GfNkhpAt9j1EHOdsOOOtVk3DloVe7alNY84JvdmkMEDaFmR2Sc3aml1Ss0ta-OfD5rkb0P3F7w0L-HIAkEsEnyDakP-5eqkYU6q4eu_wPeAmYc5mPc4pljb_v_4Pj_KQVA</recordid><startdate>20110201</startdate><enddate>20110201</enddate><creator>Melmed, Shlomo</creator><creator>Casanueva, Felipe F</creator><creator>Hoffman, Andrew R</creator><creator>Kleinberg, David L</creator><creator>Montori, Victor M</creator><creator>Schlechte, Janet A</creator><creator>Wass, John A. H</creator><general>Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20110201</creationdate><title>Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline</title><author>Melmed, Shlomo ; Casanueva, Felipe F ; Hoffman, Andrew R ; Kleinberg, David L ; Montori, Victor M ; Schlechte, Janet A ; Wass, John A. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c544t-44fcd1ccab46ae6ab86494f0f2ba709378e5cd4446b0014452da3f59ed1afd7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adenoma</topic><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Communication</topic><topic>Conferences</topic><topic>Endocrinology</topic><topic>Endocrinopathies</topic><topic>Evidence-Based Medicine</topic><topic>Feeding. Feeding behavior</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>Hyperprolactinemia</topic><topic>Hyperprolactinemia - chemically induced</topic><topic>Hyperprolactinemia - diagnosis</topic><topic>Hyperprolactinemia - etiology</topic><topic>Hyperprolactinemia - pathology</topic><topic>Hypothalamus. Hypophysis. Epiphysis (diseases)</topic><topic>Medical sciences</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><topic>Pituitary</topic><topic>Pituitary Neoplasms - complications</topic><topic>Pituitary Neoplasms - drug therapy</topic><topic>Pregnancy</topic><topic>Prolactin</topic><topic>Prolactinoma - complications</topic><topic>Prolactinoma - drug therapy</topic><topic>Side effects</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>Vertebrates: endocrinology</topic><topic>Vocalization behavior</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Melmed, Shlomo</creatorcontrib><creatorcontrib>Casanueva, Felipe F</creatorcontrib><creatorcontrib>Hoffman, Andrew R</creatorcontrib><creatorcontrib>Kleinberg, David L</creatorcontrib><creatorcontrib>Montori, Victor M</creatorcontrib><creatorcontrib>Schlechte, Janet A</creatorcontrib><creatorcontrib>Wass, John A. H</creatorcontrib><creatorcontrib>Endocrine Society</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Melmed, Shlomo</au><au>Casanueva, Felipe F</au><au>Hoffman, Andrew R</au><au>Kleinberg, David L</au><au>Montori, Victor M</au><au>Schlechte, Janet A</au><au>Wass, John A. H</au><aucorp>Endocrine Society</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2011-02-01</date><risdate>2011</risdate><volume>96</volume><issue>2</issue><spage>273</spage><epage>288</epage><pages>273-288</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels, and evidence-based approaches assess causes of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinoma.
Objective:
The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia.
Participants:
The Task Force consisted of Endocrine Society-appointed experts, a methodologist, and a medical writer.
Evidence:
This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence.
Consensus Process:
One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, The European Society of Endocrinology, and The Pituitary Society reviewed and commented on preliminary drafts of these guidelines.
Conclusions:
Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels. These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinomas in nonpregnant and pregnant subjects. Indications and side effects of therapeutic agents for treating prolactinomas are also presented.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>21296991</pmid><doi>10.1210/jc.2010-1692</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0021-972X |
| ispartof | The journal of clinical endocrinology and metabolism, 2011-02, Vol.96 (2), p.273-288 |
| issn | 0021-972X 1945-7197 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1017956608 |
| source | MEDLINE; Alma/SFX Local Collection; EZB Electronic Journals Library; Oxford Journals; Journals@Ovid Complete |
| subjects | Adenoma Adult Biological and medical sciences Communication Conferences Endocrinology Endocrinopathies Evidence-Based Medicine Feeding. Feeding behavior Female Fundamental and applied biological sciences. Psychology Humans Hyperprolactinemia Hyperprolactinemia - chemically induced Hyperprolactinemia - diagnosis Hyperprolactinemia - etiology Hyperprolactinemia - pathology Hypothalamus. Hypophysis. Epiphysis (diseases) Medical sciences Non tumoral diseases. Target tissue resistance. Benign neoplasms Pituitary Pituitary Neoplasms - complications Pituitary Neoplasms - drug therapy Pregnancy Prolactin Prolactinoma - complications Prolactinoma - drug therapy Side effects Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology Vocalization behavior |
| title | Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A15%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnosis%20and%20Treatment%20of%20Hyperprolactinemia:%20An%20Endocrine%20Society%20Clinical%20Practice%20Guideline&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Melmed,%20Shlomo&rft.aucorp=Endocrine%20Society&rft.date=2011-02-01&rft.volume=96&rft.issue=2&rft.spage=273&rft.epage=288&rft.pages=273-288&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2010-1692&rft_dat=%3Cproquest_cross%3E1017956608%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017956608&rft_id=info:pmid/21296991&rfr_iscdi=true |